Effect of cloretazine on acute myeloid leukaemia blasts in vitro as a single agent and combined with cytarabine and daunorubicin

被引：0
|
作者：
Morris, K. [1 ]
Wren, D. [1 ]
Adams, J. A. [1 ]
Yin, J. A. Liu [1 ]
机构：
[1] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1120
引用
收藏
页码：412 / 412
页数：1
相关论文
共 50 条
  • [41] CUP-LIKE BLASTS IN ACUTE MYELOID LEUKAEMIA: AN INSTITUTIONAL REVIEW
    Tan, Shi Yong
    Tam, Fung Wan
    Ang, Chieh Hwee
    Tien, Sim Leng
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 111 - 111
  • [42] Atovaquone Demonstrates Single Agent Activity and an Additive Effect in Combination with Cytotoxic Chemotherapy (Cytarabine and Daunorubicin) in AML
    Stevens, Alexandra McLean
    Munoz, Jaime Omar
    Krueger, Michael
    Horton, Terzah M.
    Redell, Michele
    BLOOD, 2017, 130
  • [43] Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
    Jost, Felix
    Schalk, Enrico
    Rinke, Kristine
    Fischer, Thomas
    Sager, Sebastian
    PLOS ONE, 2019, 14 (07):
  • [44] Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia
    Longu, Francesco
    Fozza, Claudio
    Dessi, Laura
    Longinotti, Maurizio
    Bonfigli, Silvana
    Careddu, Maria Grazia
    Coppola, Lorenzo
    Giannico, Domenica Barbara
    Nieddu, Rosa Maria
    Podda, Luigi
    Pardini, Simonetta
    Dore, Fausto
    Dore, Simone
    Sotgiu, Giovanni
    ACTA HAEMATOLOGICA, 2017, 137 (01) : 15 - +
  • [45] Cost-Effectiveness of Liposomal Cytarabine-Daunorubicin (CPX-351) Compared to Conventional Cytarabine-Daunorubicin Chemotherapy in Acute Myeloid Leukemia
    Bewersdorf, Jan Philipp
    Goshua, George
    Patel, Kishan K.
    Shallis, Rory M.
    Podoltsev, Nikolai
    Huntington, Scott F.
    Zeidan, Amer M.
    BLOOD, 2021, 138
  • [46] Mixed phenotype acute leukaemia with predominant myeloid blasts and a small subset of B/myeloid blasts shares the same mutation profile
    Capitano, Mario
    Capo-Chichi, Jose-Mario
    Minden, Mark D.
    Chang, Hong
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : E60 - E63
  • [47] Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
    Arwanih, Elly Y.
    Louisa, Melva
    Rinaldi, Ikhwan
    Wanandi, Septelia I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [48] Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia
    Brethon, Benoit
    Yakouben, Karima
    Oudot, Caroline
    Boutard, Patrick
    Bruno, Benedicte
    Jermoe, Cecile
    Nelken, Brigitte
    de Lumley, Lionel
    Bertrand, Yves
    Dalle, Jean-Hugues
    Chevret, Sylvie
    Leblanc, Thierry
    Baruchel, Andre
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (04) : 541 - 547
  • [49] Cost-effectiveness of gemtuzumab ozogamicin in combination with standard of care chemotherapy (daunorubicin and cytarabine) for first-line treatment of acute myeloid leukaemia
    Mokgokong, R.
    Mamolo, C.
    Cappelleri, J.
    Knight, C.
    Brockbank, J.
    Cawson, M.
    Dombret, H.
    Castaigne, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 43 - 44
  • [50] A Child with Acute Myeloid Leukaemia Complicated by Calcaneal Osteomyelitis due to Atypical Mycobacterial Infection after Induction Chemotherapy with Mitoxantrone, Etoposide, Cytarabine and Daunorubicin
    Chan, W.
    Lee, P.
    Chiang, A.
    Cheuk, D.
    Chan, G.
    Ha, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S501 - S502
12345